$KNSA filed an 8-K with results (Item 2.02) at 7:32 AM ET on Tue, Oct 27.
0 replies · 0 points
KNSA
Kiniksa Pharmaceuticals International, plc Class A · NASDAQ
Sign up free to see this.
Why it moved
Filed an 8-K today reporting results of operations. · per SEC
Sources: SEC
From SEC filing · Not investment advice
Mkt Cap
$7B
Volume
1.3M
52W High
$84.06
52W Low
$35.20
PE Ratio
86.9
Avg Vol
630.3K
As of 10/26/26
Div Yield
0.35%
Beta
0.25
As of 10/26/26
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
At least 5 tagged posts are needed.
How do you feel about KNSA?
Board · 0 threads
Open board ›Cylvex posts are automated counts of published analyst actions, not opinions. Not investment advice.